The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians.
Medicine by Design is pleased to welcome Karen Hirschi, PhD, for a talk titled, ‘Regulation of Endothelial Specialization in Development and Disease.’
Karen Hirschi is an Alumni Professor of Cell Biology, University of Virginia School of Medicine, Director, UVA Developmental Genomics Center, Associate Director for Scientific Programs, UVA Medical Scientist Training Program, and Adjunct Professor, Yale University School of Medicine & Baylor College of Medicine.
This event will be held at the Terrence Donnelly Centre for Cellular & Biomolecular Research, Red Room.
About Karen Hirschi
Karen K. Hirschi received an Honors BS at Pennsylvania State University and PhD in Nutritional Biochemistry at the University of Arizona. She did her postdoctoral training in vascular cell and developmental biology at Harvard Medical School, and began her first tenure-track faculty position at Baylor College of Medicine, where she became a tenured Professor and was the founding Deputy Director of the Stem Cell and Regenerative Medicine Center. Dr. Hirschi moved to Yale University School of Medicine, where she served as a Professor in the Departments of Medicine and Genetics and as a Co-Director of the Cardiovascular Research Center. Her lab is currently at University of Virginia School of Medicine, where she serves as the Alumni Professor of Cell Biology and founding Director of the Developmental Genomics Center that focuses on identifying genetic mutations that cause developmental disorders. The Hirschi lab is primarily interested in vascular development and focuses on elucidating regulators of endothelial cell differentiation and specialization, as well as modulators of endothelial cell proliferation during vessel formation. They use the mouse model system to study the regulation of these processes in vivo. Insights gained are applied to the modulation of the commitment of pluripotent human stem cells toward vascular cell fates, and to the genesis and optimization of clinically relevant strategies to promote endogenous vascular regeneration and repair in disease conditions.